
Get exclusive money-saving offers and guides
Straight to your inbox
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Cryosite Limited is a diagnostics & research business based in Australia. Cryosite shares (CTE) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Cryosite has a trailing 12-month revenue of around $9 million.
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
52-week range | $0.05 - $0.46 |
---|---|
50-day moving average | $0.3725 |
200-day moving average | $0.2856 |
Target price | N/A |
PE ratio | 7.1667 |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $0.03 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Cryosite stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cryosite 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cryosite 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, Cryosite shares trade at around 7x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Cryosite 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $952,651 (£528,567).
The EBITDA is a measure of a Cryosite 's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $9 million |
---|---|
Operating margin TTM | 8.5% |
Gross profit TTM | $4 million |
Return on assets TTM | 2.04% |
Return on equity TTM | 0% |
Profit margin | 16.5% |
Book value | -0.037 |
Market capitalisation | $10.1 million |
TTM: trailing 12 months
We're not expecting Cryosite to pay a dividend over the next 12 months.
Cryosite 's shares were split on 28 April 2004.
Over the last 12 months, Cryosite 's shares have ranged in value from as little as $0.05 up to $0.46. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Cryosite 's is 0.2686. This would suggest that Cryosite 's shares are less volatile than average (for this exchange).
Cryosite Limited engages in the supply chain logistics and management of pharmaceutical products used in clinical trials, and biological materials in Australia. It operates in two segments, Clinical Trials & Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials & Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, and biological storage services to the clinical trial and research industry. The Cord Blood and Tissues Storage segment offers long term storage for cord blood and tissue samples. It serves research, medical, pharmaceutical, veterinary, and biotechnology industries. Cryosite Limited was founded in 1999 and is based in South Granville, Australia.
Robinhood is set to go public as soon as June. Here's what you need to do to buy in from Australia.
We explain everything you need to make your own retro arcade machine, built around the super-flexible Raspberry Pi.
Beat the banks, find the best exchange rates and avoid fees when you send money abroad from Australia.
All the key info you need to know to sell shares you inherited or received as a gift.
Steps to owning and managing Roblox shares.
Everything we know about the Deliveroo IPO, plus information on how to buy in.
Steps to owning and managing Zebit shares.
Steps to owning and managing CleanSpace shares.